ROME: Millions of Ita-lians braced on Saturday under stern new coronavirus restrictions for Christmas and New Year as Europe fought a winter surge in infections and Switzerland became the newest nation to authorise a vaccine for the virus.
Since the pandemic broke out a year ago, Europe has been the first region in the world to reach 500,000 Covid-19 casualties, killing more than 1.6 million worldwide and pitching the global economy into chaos.
Until January 6, Italy became the newest country to declare a new restriction system, which included restrictions on people leaving their homes more than once a day, closure of non-essential stores, bars and restaurants, and municipal travel curbs.
Claudia Patrone, a 33-year-old prosecutor, said as she got off a train in Milan, “It’s right that they prohibit departures after 20 December if that means travelling in safety.”
Before I left, I took the exam, I remained locked in my building, and I saw nobody. If everybody follows the laws and ensures immunity, the measure is right.” Europe, the epicentre of the pandemic earlier this year is again seeing increasing cases of officials fearing an explosion of infections after the Christmas holidays as families gather.”
The accelerated rollout of vaccines is still seen as the most viable solution to end the pandemic and the economically crippling lockdowns used to halt its propagation a year since the pandemic first appeared in the Chinese city of Wuhan.
After Christmas, Europe is set to launch a huge vaccine programme after the United States and Britain, who have started to send jabs with an authorised Pfizer-BioNTech injection, one of the leading candidates.
Russia and China have already begun to hand out jabs of their own vaccines manufactured domestically.
On Saturday, Swiss regulators gave the Pfizer-BioNTech vaccine the green light, the 16th country to do so and the first in continental Europe, with immunisation expected to begin within days.
In a video tweet, Health Minister Alain Berset said, “Those who are particularly vulnerable will have priority, namely older people and those with pre-existing conditions.”
On Friday, the United States approved Mode-Covid-19 rna’s vaccine for emergency use, paving the way for millions of second jab doses to be delivered across the world’s hardest-hit region.